1. Introduction {#sec1}
===============

Essential medicines satisfy people\'s desire for health; they are selected through cost-effectiveness comparison and according to the current situation, effectiveness, and safety of public health \[[@B1], [@B2]\]. The establishment of essential medicines list of China has been based on the directory of WHO \[[@B3], [@B4]\].

Although many reports which used the ADR database to advance the safety of drugs have been published \[[@B5], [@B6]\], there are also authors who based on the small sample of ADR of individual breeds analyzed essential medicines list of China \[[@B7]\]. These earlier findings lead us to other imperative, comprehensive, and updated questions. The goal of this study was to characterize the differences between the two essential medicines recorded in China\'s national essential medicines list (2015) \[[@B8]\] and WHO model list of essential medicines (19th edition) \[[@B9]\], considering classification, number of ADRs, type of report, and the way of administration during the period 2013-2015. The data comes from National Center for ADR Monitoring of Jiangsu Province.

2. Materials and Methods {#sec2}
========================

China\'s national essential medicines list (2015 edition) and WHO model list of essential medicines (19th edition) were obtained from the ministry of health website. Using the database of Jiangsu Province ADR Monitoring Center from 2013 to 2015 to perform a retrospective study, we analyze the differences between the two essential medicines recorded in China\'s and WHO lists with ADR by the number, type of report, and the way of administration. Analyses employed descriptive statistics and chi square test.

3. Results {#sec3}
==========

3.1. Comparison of the Occurrence of ADR with Medicines Recorded in China\'s and WHO Lists {#sec3.1}
------------------------------------------------------------------------------------------

There are 373 essential medicines recorded in WHO and 301 in China. The same species are 117. A total of 266869 cases of ADR were discharged within this period, with 76282 cases occurring in essential medicines recorded in China and 48310 cases in WHO. Among them, the most ADR are all anti-infective adjust water, electrolyte, and acid-base balance medicines. The second are respiratory medicines, medicines for pain and palliative care, and gastrointestinal medicines. The number of ADRs of these medicines in China\'s list is significantly higher than that in WHO ([Table 1](#tab1){ref-type="table"}).

3.2. Comparison of the Type of ADR {#sec3.2}
----------------------------------

It is presents the characteristics of the type of ADR discharged in the two essential medicines list ([Table 2](#tab2){ref-type="table"}). Comparing the China\'s essential medicines list with number of ADRs with WHO, they have higher new and new severe adverse events (12601 and 820) and lower number of severe adverse events (2714). When comparing the type of new, new severe, and severe adverse events, all results are statistically significant (p\<0.01).

3.3. Comparison of the Modes of Administration of ADR {#sec3.3}
-----------------------------------------------------

It is illustrate that oral, intravenous drip, external use, local, Yin/intestinal administration, and inhalation are the main modes of administration for adverse reactions to essential medicines recorded in China and WHO list ([Figure 1](#fig1){ref-type="fig"}). Also it was found that oral and intravenous drip modes of administration have the highest proportion, 47.0% and 51.8% in essential medicines list of China and 34.2% and 64.3% in WHO essential medicines list. The other modes of administration have a lower ratio.

4. Discussion {#sec4}
=============

In recent years, the ADR reporting systems have been providing a basis for drug safety evaluation. There are authors who showed the necessity and feasibility of using big data to study the research on active monitoring of drugs \[[@B10], [@B11]\]. According to the China Food and Drug Administration (CFDA) "annual report on national drug adverse reaction monitoring" (2015), 1398, 000 ADR reports have been reported in nationwide. However, nearly 90,000 reports have been reported annually in Jiangsu Province, accounting for 6.4 percent of the national sample size. It can reflect the overall situation of the national ADR.

Therefore, exploring the safety of the drugs recorded in China\'s essential medicines list based on a large sample is necessary. The results showed that the number of ADRs in China\'s list was much higher than that of the WHO.

It is necessary to discuss the safety of the drugs recorded in China\'s essential medicines list based on the large sample data. The results showed that the number of ADRs in China\'s list was much higher than that of the WHO. Among them, anti-infective medicine and regulating water, electrolyte, and acid-base balance drugs have the most ADR ([Table 1](#tab1){ref-type="table"}) and China was also higher than WHO. This is closely related to its usage amount, but we should pay more attention to irrational drug-induced ADR. The use of anti-infective drugs without indications, long course of treatment, and unreasonable preventive are very universal in clinical practice \[[@B12]\].

In addition, comparing from the type of report ([Table 2](#tab2){ref-type="table"}), they have higher new and new severe and lower number of severe adverse events. Many factors can be associated with ADRs in it. Although 117 drugs are the same as recorded in the two lists, most are not the same. The ADRs caused by the different varieties of drugs in the two catalogues were identified as possible factors. In addition, many of the adverse reactions are associated with specific factors related to the patient and/or with the drug, like some drugs have a certain repeated type of ADR. Combined with China and WHO essential medicines list, drugs with more or severe ADR can be reevaluated and screened as a reference for screening of essential drugs in China \[[@B13]\].

In administration, our study shows that oral and intravenous drips have the highest proportion, in the two essential medicines lists. The other modes of administration have a lower ratio. The reason may be due to injection and injection of sterile powder compared with other medication, endotoxin, pH, osmotic pressure, and particles and other internal factors are more likely to lead to ADR in injection \[[@B14]\]. Oral administration is relative to a large number of applications \[[@B15]\].

Therefore, we should pay close attention to the patient\'s complaints and first-line clinical feedback of adverse reactions. For the revision of China\'s essential medicines list, an updated drug manual provides the most stringent basis \[[@B16]\].
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###### 

The occurrence of ADR with medicines recorded in China\'s and WHO list.

  ------------------------------------------------------------------------------------------------------------------------------------------------
  Drug classification     WHO model list   China\'s list   The same number   WHO essential medicines   China essential medicines           
  ----------------------- ---------------- --------------- ----------------- ------------------------- --------------------------- ------- -------
  Anti-infective          76               55              27                18128                     37.52                       24735   32.43

  Anthelminthics          31               9               7                 495                       1.02                        937     0.23

  anaesthetics            13               4               2                 455                       0.94                        28      0.03

  Medicines for pain\     34               18              4                 4089                      7.65                        6469    8.48
  and palliative care                                                                                                                      

  The nervous system      9                18              7                 959                       1.99                        3116    4.08

  Medicines used in\      14               6               3                 2768                      5.73                        516     0.68
  mood disorders                                                                                                                           

  Cardiovascular          21               31              13                1958                      4.05                        6146    8.06

  Respiratory\            5                8               1                 229                       0.47                        3103    4.07
  medicines                                                                                                                                

  Gastrointestinal\       10               29              4                 1673                      3.46                        4308    5.65
  medicines                                                                                                                                

  Urinary medicines       5                7               3                 971                       2.01                        592     0.78

  Medicines affecting\    22               16              4                 657                       1.36                        1698    2.23
  the blood                                                                                                                                

  Endocrine\              23               21              4                 1398                      3.10                        1941    2.54
  medicines                                                                                                                                

  Antiallergic\           5                5               1                 983                       2.04                        1111    1.46
  medicines                                                                                                                                

  Immune system\          4                2               1                 61                        0.13                        82      0.11
  medicines                                                                                                                                

  Vitamins, minerals      12               15              2                 110                       0.23                        2156    2.83

  Adjust water,\          9                9               6                 11266                     23.87                       15762   20.66
  electrolyte and acid\                                                                                                                    
  base balance                                                                                                                             

  Antidotes               15               6               3                 203                       0.48                        132     0.17

  Biological products     8                4               2                 28                        0.06                        1098    1.44

  Diagnostic agents       7                2               1                 326                       0.68                        32      0.04

  Dermatological\         16               12              9                 730                       1.51                        418     0.55
  medicines                                                                                                                                

  Ophthalmic\             13               13              9                 142                       0.29                        439     0.57
  medicines                                                                                                                                

  Ear and nose\           4                3               0                 68                        0.14                        70      0.09
  medicines                                                                                                                                

  obstetrics and\         4                7               3                 515                       1.07                        1260    1.65
  gynecology\                                                                                                                              
  medicine                                                                                                                                 

  Family planning\        13               1               1                 98                        0.20                        133     0.17
  medicines                                                                                                                                

                          373              301             117               48310                     100                         76282   100
  ------------------------------------------------------------------------------------------------------------------------------------------------

Note: repeat medication for one

###### 

Comparetion the type of the ADR.

          Total   New     Sever   New severe                       
  ------- ------- ------- ------- ------------ ------ ------ ----- -----
  2013    23234   13705   4449    2253         932    2199   256   187
  2014    21618   14882   4134    2280         877    2827   272   227
  2015    23751   18928   4018    2729         905    2540   292   302
  Totle   68603   47515   12601   7262         2714   7566   820   716

Note: using chi square test to compare the differences between the two groups of drugs in the presence of new, severe, and new serious adverse events; statistically significant (p\<0.05). New: the adverse reactions are not specified in the drug specification. Severe: reaction to one of the following, damage caused by taking a drug: ① death; ② carcinogenic, teratogenic, or birth defects; ③ dangerous to life and can cause permanent or significant disability; ④ permanent damage to organ function; and ⑤ being hospitalized or staying in hospital for too long. New severe: the adverse reactions are severe and not specified in the drug specification.
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